Karachi, GlaxoSmithKline Pakistan, a longstanding entity in the pharmaceutical landscape, showcased an EPS of Rs. 77 for the recent quarter. Trading began at Rs. 91.34, peaking at Rs. 3,184.67. No dividends or bonuses were declared this period. GlaxoSmithKline Pakistan has been listed since 1953 and trades with a lot size of 500 shares.